Last updated: October 14, 2024
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild
Overall Status: Active - Recruiting
Phase
N/A
Condition
Multiple Sclerosis
Memory Loss
Neurologic Disorders
Treatment
MP2RAGE sequence
Clinical Study ID
NCT06589999
ALR_2024_2
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patient aged over 18 years
scheduled to undergo 1.5T or 3T MRI of the spinal cord as part of an initialassessment or reassessment of inflammatory neuraxial disease.
Express consent to participate in the study
Member or beneficiary of a social security scheme
Exclusion
Exclusion Criteria:
Patient benefiting from a legal protection measure
Pregnant women
Absolute or relative contraindication to 1.5T or 3T MRI
Study Design
Total Participants: 196
Treatment Group(s): 1
Primary Treatment: MP2RAGE sequence
Phase:
Study Start date:
July 31, 2024
Estimated Completion Date:
July 31, 2026
Connect with a study center
Hopital Fondation Adolphe de Rothschild
Paris,
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.